{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:24:24Z","timestamp":1791051864876,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T00:00:00Z","timestamp":1316736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1750-9378-6-s2-s7","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T18:22:14Z","timestamp":1316802134000},"source":"Crossref","is-referenced-by-count":6,"title":["Bone mineral density in Jamaican men on androgen deprivation therapy for prostate cancer"],"prefix":"10.1186","volume":"6","author":[{"given":"Belinda F","family":"Morrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E","family":"Burrowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G","family":"Mayhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace M","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin E","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,23]]},"reference":[{"key":"290_CR1","volume-title":"Demographic Statistics 2007","author":"The Statistical institute of Jamaica","year":"2007","unstructured":"The Statistical institute of Jamaica: Demographic Statistics 2007. 2007, Kingston: Stepehnson's Litho Press"},{"issue":"2","key":"290_CR2","first-page":"81","volume":"57","author":"T Gibson","year":"2008","unstructured":"Gibson T, Blake G, Hanchard B, Waugh N, McNaughton D: Age-specific incidence of cancer in Kingston and St. Andrew, 1998-2002. West Indian Med J. 2008, 57 (2): 81-89.","journal-title":"West Indian Med J"},{"issue":"2","key":"290_CR3","first-page":"64","volume":"51","author":"G Blake","year":"2002","unstructured":"Blake G, Hanchard B, Mitchell K, Simpson D, Waugh N, Wolff C, Samuels E: Jamaica cancer mortality statistics, 1999. West Indian Med J. 2002, 51 (2): 64-67.","journal-title":"West Indian Med J"},{"issue":"11","key":"290_CR4","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/j.1464-410X.2008.08265.x","volume":"103","author":"KC Coard","year":"2009","unstructured":"Coard KC, Skeete DH: A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica. BJU Int. 2009, 103 (11): 1482-1486. 10.1111\/j.1464-410X.2008.08265.x.","journal-title":"BJU Int"},{"issue":"4","key":"290_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1046\/j.1464-4096.2001.01871.x","volume":"89","author":"SE Shirley","year":"2002","unstructured":"Shirley SE, Escoffery CT, Sargeant LA, Tulloch T: Clinicopathological features of prostate cancer in Jamaican men. BJU Int. 2002, 89 (4): 390-395. 10.1046\/j.1464-4096.2001.01871.x.","journal-title":"BJU Int"},{"issue":"6","key":"290_CR6","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0022-5347(01)63220-8","volume":"159","author":"FE Glover Jr.","year":"1998","unstructured":"Glover FE, Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T, Baker TD, Wan RL, Walsh PC: The epidemiology of prostate cancer in Jamaica. J Urol. 1998, 159 (6): 1984-1986. 10.1016\/S0022-5347(01)63220-8. discussion 1986-1987","journal-title":"J Urol"},{"issue":"11","key":"290_CR7","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/j.1464-410X.2008.07933.x","volume":"102","author":"P Hakimian","year":"2008","unstructured":"Hakimian P, Blute M, Kashanian J, Chan S, Silver D, Shabsigh R: Metabolic and cardiovascular effects of androgen deprivation therapy. BJU Int. 2008, 102 (11): 1509-1514. 10.1111\/j.1464-410X.2008.07933.x.","journal-title":"BJU Int"},{"issue":"8","key":"290_CR8","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1210\/jcem.87.8.8782","volume":"87","author":"D Mittan","year":"2002","unstructured":"Mittan D, Lee S, Miller E, Perez RC, Basler JW, Bruder JM: Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab. 2002, 87 (8): 3656-3661. 10.1210\/jc.87.8.3656.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"290_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","volume":"163","author":"HW Daniell","year":"2000","unstructured":"Daniell HW, Dunn SR, Ferguson DW, Lomas G, Niazi Z, Stratte PT: Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol. 2000, 163 (1): 181-186. 10.1016\/S0022-5347(05)68000-7.","journal-title":"J Urol"},{"issue":"2","key":"290_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa041943","volume":"352","author":"VB Shahinian","year":"2005","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS: Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005, 352 (2): 154-164. 10.1056\/NEJMoa041943.","journal-title":"N Engl J Med"},{"issue":"3","key":"290_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0022-5347(05)64561-2","volume":"168","author":"MG Oefelein","year":"2002","unstructured":"Oefelein MG, Ricchiuti V, Conrad W, Resnick MI: Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol. 2002, 168 (3): 1005-1007. 10.1016\/S0022-5347(05)64561-2.","journal-title":"J Urol"},{"issue":"5","key":"290_CR12","first-page":"1137","volume":"75","author":"T Yuasa","year":"1131","unstructured":"Yuasa T, Maita S, Tsuchiya N, Ma Z, Narita S, Horikawa Y, Yamamoto S, Yonese J, Fukui I, Takahashi S: Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients. Urology. 1131, 75 (5): 1137-","journal-title":"Urology"},{"issue":"2","key":"290_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00198-007-0450-9","volume":"19","author":"DD Hill","year":"2008","unstructured":"Hill DD, Cauley JA, Sheu Y, Bunker CH, Patrick AL, Baker CE, Beckles GL, Wheeler VW, Zmuda JM: Correlates of bone mineral density in men of African ancestry: the Tobago bone health study. Osteoporos Int. 2008, 19 (2): 227-234. 10.1007\/s00198-007-0450-9.","journal-title":"Osteoporos Int"},{"key":"290_CR14","volume-title":"Anthropometric Standardization Reference Manual","author":"T Lohman","year":"1988","unstructured":"Lohman T, Roche A, Martorell R: Anthropometric Standardization Reference Manual. 1988, Champaign, Illinois"},{"issue":"6","key":"290_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0302-2838(03)00379-8","volume":"44","author":"J Morote","year":"2003","unstructured":"Morote J, Martinez E, Trilla E, Esquena S, Abascal JM, Encabo G, Reventos J: Osteoporosis during continuous androgen deprivation: influence of the modality and length of treatment. Eur Urol. 2003, 44 (6): 661-665. 10.1016\/S0302-2838(03)00379-8.","journal-title":"Eur Urol"},{"issue":"4","key":"290_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0090-4295(99)00301-5","volume":"54","author":"JT Wei","year":"1999","unstructured":"Wei JT, Gross M, Jaffe CA, Gravlin K, Lahaie M, Faerber GJ, Cooney KA: Androgen deprivation therapy for prostate cancer results in significant loss of bone density. Urology. 1999, 54 (4): 607-611. 10.1016\/S0090-4295(99)00301-5.","journal-title":"Urology"},{"issue":"3","key":"290_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/cncr.20388","volume":"101","author":"TL Krupski","year":"2004","unstructured":"Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q, Botteman M, Litwin MS: Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer. 2004, 101 (3): 541-549. 10.1002\/cncr.20388.","journal-title":"Cancer"},{"issue":"12","key":"290_CR18","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/1097-0142(20010615)91:12<2238::AID-CNCR1254>3.0.CO;2-2","volume":"91","author":"MR Smith","year":"2001","unstructured":"Smith MR, McGovern FJ, Fallon MA, Schoenfeld D, Kantoff PW, Finkelstein JS: Low bone mineral density in hormone-naive men with prostate carcinoma. Cancer. 2001, 91 (12): 2238-2245. 10.1002\/1097-0142(20010615)91:12<2238::AID-CNCR1254>3.0.CO;2-2.","journal-title":"Cancer"},{"issue":"6","key":"290_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.eururo.2004.08.016","volume":"46","author":"F Saad","year":"2004","unstructured":"Saad F, Olsson C, Schulman CC: Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care. Eur Urol. 2004, 46 (6): 731-739. 10.1016\/j.eururo.2004.08.016. discussion 739-740","journal-title":"Eur Urol"},{"issue":"5 Suppl","key":"290_CR20","doi-asserted-by":"publisher","first-page":"505S","DOI":"10.1016\/8756-3282(95)00258-4","volume":"17","author":"BL Riggs","year":"1995","unstructured":"Riggs BL, Melton LJ: The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995, 17 (5 Suppl): 505S-511S.","journal-title":"Bone"},{"issue":"3","key":"290_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0302-2838(03)00007-1","volume":"43","author":"MT Groot","year":"2003","unstructured":"Groot MT, Boeken Kruger CG, Pelger RC, Uyl-de Groot CA: Costs of prostate cancer, metastatic to the bone, in the Netherlands. Eur Urol. 2003, 43 (3): 226-232. 10.1016\/S0302-2838(03)00007-1.","journal-title":"Eur Urol"},{"issue":"9","key":"290_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.7326\/0003-4819-148-9-200805060-00008","volume":"148","author":"A Qaseem","year":"2008","unstructured":"Qaseem A, Snow V, Shekelle P, Hopkins R, Forciea MA, Owens DK: Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008, 148 (9): 680-684.","journal-title":"Ann Intern Med"},{"issue":"8","key":"290_CR23","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/ndt\/14.8.1917","volume":"14","author":"MW Taal","year":"1999","unstructured":"Taal MW, Cassidy MJ, Pearson D, Green D, Masud T: Usefulness of quantitative heel ultrasound compared with dual-energy X-ray absorptiometry in determining bone mineral density in chronic haemodialysis patients. Nephrol Dial Transplant. 1999, 14 (8): 1917-1921. 10.1093\/ndt\/14.8.1917.","journal-title":"Nephrol Dial Transplant"},{"issue":"865","key":"290_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1259\/bjr.73.865.10721317","volume":"73","author":"CM Langton","year":"2000","unstructured":"Langton CM, Langton DK: Comparison of bone mineral density and quantitative ultrasound of the calcaneus: site-matched correlation and discrimination of axial BMD status. Br J Radiol. 2000, 73 (865): 31-35.","journal-title":"Br J Radiol"},{"issue":"6 Pt 1","key":"290_CR25","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1097\/01.ju.0000145511.56476.00","volume":"172","author":"JL Ockrim","year":"2004","unstructured":"Ockrim JL, Lalani EN, Banks LM, Svensson WE, Blomley MJ, Patel S, Laniado ME, Carter SS, Abel PD: Transdermal estradiol improves bone density when used as single agent therapy for prostate cancer. J Urol. 2004, 172 (6 Pt 1): 2203-2207.","journal-title":"J Urol"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-6-S2-S7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-9378-6-S2-S7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-6-S2-S7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:37:50Z","timestamp":1548128270000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-6-S2-S7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,23]]},"references-count":25,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-6-s2-s7","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,23]]},"article-number":"S7"}}